The place of surgery in M1a disease

G. Massard (Strasbourg, France)

Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Session: Which treatment other than chemotherapy for stage IV NSCLC?
Session type: Symposium
Number: 1462
Disease area: Thoracic oncology

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Massard (Strasbourg, France). The place of surgery in M1a disease. Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Is surgical resection of M1a lung adenocarcinoma with metastatic pleural nodules really a useless choice?
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

The management of single metastasis in stage M1b
Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Year: 2013

Coronary artery disease and lung cancer surgery
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006

Locally advanced disease – indications and results of extended resections
Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer
Year: 2005

Sublobar resections vs lobectomy for early stage lung cancer: where do we stand?
Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process?
Year: 2020

Bronchoplastic lobectomy: does the disease influence on the result?
Source: Eur Respir J 2003; 22: Suppl. 45, 367s
Year: 2003

Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

The role of surgery in pleural disease
Source: Eur Respir Monogr 2020; 87: 263-281
Year: 2020

Interval versus continuous training in patients with end stage lung disease before lung transplantation
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009

Indications and results of resectional surgery for limited disease
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006

Disease relapse after radical surgery of NSCLC
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007

Role of surgical management in oligometastatic disease
Source: International Congress 2019 – New perspectives in thoracic surgical oncology
Year: 2019

Is the lung emphysema contraindication to radical NSCLC surgery?
Source: Eur Respir J 2001; 18: Suppl. 33, 94s
Year: 2001

Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables.
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019

Parenchyma-sparing sleeve resection in advanced nodal disease of NSCLC
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010

Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy
Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery
Year: 2007